Stocks
ImmunoGen (IMGN) EBITDA margin US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -285.1% | -79.9% | -14.9% | -177.8% | -198.3% | -21.8% | ||
| Changes by years, y/y, % | -237pp | +205pp | +65pp | -163pp | -21pp | +32.7% | |||
ImmunoGen. EBITDA margin, %
ImmunoGen. EBITDA margin, changes, pp
ImmunoGen (IMGN) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| EBITDA margin, % | ? | -507.3% | -131.4% | -76.1% | -2.24% | 27.4% | -21.8% | |
| Changes by years, y/y, % | -137pp | -8pp | -17pp | +427pp | +535pp | |||
| Changes by quarters, q/q, % | -78pp | +376pp | +55pp | +74pp | +30pp | |||
